PKP-005 Effect of ERB2 ile655val polymorphism on trastuzumab-induced cardiotoxicity in women with HER2-positive breast cancer | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Pharmacokinetics and Pharmacodynamics

PKP-005 Effect of ERB2 ile655val polymorphism on trastuzumab-induced cardiotoxicity in women with HER2-positive breast cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Gómez Peña C, García Fernández C, Dávila Fajardo C, et al

PKP-005 Effect of ERB2 ile655val polymorphism on trastuzumab-induced cardiotoxicity in women with HER2-positive breast cancer

European Journal of Hospital Pharmacy 2014;21:A138.